Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
Core EBITDA Growth

    Back to All Ratios
ORCHID PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 2.2036.8263.14-3.4820.95

What is the latest Core EBITDA Growth ratio of ORCHID PHARMA ?

The latest Core EBITDA Growth ratio of ORCHID PHARMA is 2.20 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar20252.20
Mar202436.82
Mar202363.14
Mar2022-3.48
Mar202120.95

How is Core EBITDA Growth of ORCHID PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 2.2
-94.02
Mar2024 36.82
-41.69
Mar2023 63.14
Positive
Mar2022 -3.48
Negative
Mar2021 20.95 -

Other Financial Ratios of ORCHID PHARMA


Compare Core EBITDA Growth ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹3,186.5 Cr 11.1% 24.8% -24.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,848.0 Cr 11.6% 0.7% -0.4% Stock Analytics
DIVIS LABORATORIES ₹172,697.0 Cr 2.3% 8.5% 8.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,859.0 Cr 1.8% -1.8% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹110,421.0 Cr 0.5% 3.2% 13.3% Stock Analytics
CIPLA ₹105,811.0 Cr 1.2% 5.4% -13.7% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

11.1%

24.8%

-24.5%

SENSEX

-1%

2.2%

-3.6%


You may also like the below Video Courses